The continued treatment with Xtandi , plus abiraterone acetate and prednisone as compared to treatment with abiraterone acetate and prednisone alone, did not meet its primary endpoint of improvement
Actelion said there can be no certainty at this point that any transaction will result. The company said: “No further statement will be made until such time Actelion
The decision follows a pre-planned review of safety data. RHB-104 is an antibiotic combination therapy in oral capsule formulation, with potent intracellular, anti-mycobacterial and anti-inflammatory properties. It has
SAGE-217 is a next generation positive allosteric modulator that has been optimized for selectivity to synaptic and extrasynaptic GABA receptors and a pharmacokinetic profile aimed for daily oral
BlueRock Therapeutics will develop induced pluripotent stem cell (iPSC) therapies for treating various diseases. The funds are expected to give the new company at least four years of runway and enable
Several publications have recently reported that Lonza is in final discussions with Kohlberg Kravis Roberts (KKR) regarding the potential acquisition. The Swiss firm is of view that Capsugel
The phase III Monaleesa-2 study showed superior PFS with LEE011 plus letrozole in pre-defined patient subgroups, from de novo to bone, liver and lung metastases, compared to letrozole alone.
The companies signed a worldwide agreement to co-develop MEDI1814, an antibody selective for amyloid-beta 42 (Aβ42), which is presently in phase I trials. The deal builds on the
FA is a life-shortening and degenerative neuro-muscular disorder that affects nearly 4,000 to 6,000 people in the US. The placebo-controlled trial, Steadfast, failed to demonstrate that Actimmune therapy resulted
Researchers have shown that using LED lights flickering at a specific frequency they can reduce the beta amyloid plaques seen in Alzheimer’s disease, in the visual cortex of mice.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.